Prapela
Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, visit prapela.com
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
3
tools in use
Monthly traffic
30
organic / mo
Sign up free to see all 3 verified contacts at Prapela
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- DM
David Morrill
VP, Product Development · Other
EmailPhone - JK
John Konsin
Principal Founder and Chief Executive Officer · Other
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Prapela
2 distinct titles indexed · top 2 shown.
- 1principal founder and chief executive officer
- 1vp, product development
Sign up to unlock all 3 contacts at Prapela
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Prapela
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.